Explore more
News
Merck, vaccine and Robert F. Kennedy Jr.
Digest more
Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from ...
Merck Manuals, a comprehensive digital health resource, announced today it has launched a new search tool enhanced by artificial intelligence to provide patients and other health care consumers with ...
Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...
One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...
There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...
She came from Johnson&Johnson where she served the same role at the company’s medical devices segment. Chief Marketing Officer of Human Health Chirfi Guindo is Merck’s Chief Marketing Officer ...
Get the detailed quarterly/annual income statement for Merck & Co., Inc. (MRK). Find out the revenue, expenses and profit or loss over the last fiscal year.
Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback